2012
DOI: 10.1074/jbc.m111.300137
|View full text |Cite
|
Sign up to set email alerts
|

Tumor Necrosis Factor (TNF) Receptor-associated Factor 7 Is Required for TNFα-induced Jun NH2-terminal Kinase Activation and Promotes Cell Death by Regulating Polyubiquitination and Lysosomal Degradation of c-FLIP Protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(28 citation statements)
references
References 42 publications
0
26
1
Order By: Relevance
“…20, 21, 39 Data from Figure 5c illustrate that the proteasome inhibitor MG132 inhibited the hyperthermia-mediated downregulation of c-FLIP L , but there was no restoration of c-FLIP L for lysosomal proteases inhibitor NH 4 Cl, confirming the existence of proteasome-mediated, but not lysosome-mediated, degradation of the protein. Ubiquitination assays further proved that the ubiquitination of c-FLIP L increased upon hyperthermia.…”
Section: Discussionmentioning
confidence: 88%
See 1 more Smart Citation
“…20, 21, 39 Data from Figure 5c illustrate that the proteasome inhibitor MG132 inhibited the hyperthermia-mediated downregulation of c-FLIP L , but there was no restoration of c-FLIP L for lysosomal proteases inhibitor NH 4 Cl, confirming the existence of proteasome-mediated, but not lysosome-mediated, degradation of the protein. Ubiquitination assays further proved that the ubiquitination of c-FLIP L increased upon hyperthermia.…”
Section: Discussionmentioning
confidence: 88%
“…19 Indeed, several studies show that c-FLIP L is degraded via the proteasome or lysosome pathway. 20, 21 To verify which pathway was involved in hyperthermia-induced downregulation of c-FLIP L , we used the proteasome inhibitor MG132 and lysosomal proteases inhibitor ammonium chloride (NH 4 Cl). Figure 5c shows that treatment with MG132, but not NH 4 Cl, restored c-FLIP L expression completely, confirming the existence of proteasome-mediated degradation of the protein, whereas lysosome-mediated degradation was not involved.…”
Section: Resultsmentioning
confidence: 99%
“…However, the conditions required for differentiation and related mechanisms of OC precursors are not yet understood, which impedes the prevention and treatment of this disease. As an important inflammatory initiating factor, tumor necrosis factor-α (TNF-α) plays a critical role in the differentiation of multiple inflammatory and tumor cells (Scudiero et al, 2012). Vessel endothelial growth factor (VEGF) works as an angiogenesis regulating factor and has shown a powerful accelerating function of fracture healing in some studies (Won et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…One of the protein families that bind to both TNFRs is the TNF receptor-associated factors (TRAFs) [3,4]. Up to now, seven members of the TRAF family have been described [4,5]. All the TRAFs contain a C-terminal TRAF domain that mediates the interaction with TNF receptors and hetero- or homodimerization among the TRAF family members [3].…”
Section: Introductionmentioning
confidence: 99%
“…TRAF1 can associate with multiple TNFR family members and can also bind several protein kinases and adaptor proteins, suggesting that it likely possesses multiple functions in cytokine signaling networks [15]. TRAF7 is the last member of the TRAF family that has been identified and recent data indicate that TRAF7 regulates the activation of cellular stress pathways, as well as unconventional ubiquitination events and differentiation of muscle tissue [5]. TRAF2, TRAF3 and TRAF6 are E3 ubiquitine ligases that play a pivotal role in the control of NF-κB activation by innate and adaptive immunity stimuli [16].…”
Section: Introductionmentioning
confidence: 99%